UNSPSC 51203303: Pomalidomide

This classification denotes an immunosuppressant, a biological preparation with the molecular formula C13H11N3O4 and that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D2UX06XLB5, chemically known as 4-Amino-2-(2,6-dioxo-3-piperidyl)isoindoline-1,3-dione or 4-Aminothalidomide but more commonly known as pomalidomide, which bears US NIH Compound Identifier 134780. The term POMALIDOMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 1, 2008, List 59).

European Medicines Agency schedules pomalidomide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB33379. SMILES: C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N.

UNSPSC 51203303 Pomalidomide is a Commodity code that in practice encompasses a broader range of pharmaceutical and medical products than its nominal designation suggests, including naloxone, drug deactivation systems, medical and first aid supplies, and generic pharmaceuticals procured by state and local health agencies, fire departments, and cooperative purchasing alliances. State and local governments buy these products through competitive sealed bidding and request-for-proposal processes to support emergency response operations, public health initiatives, and pharmacy benefit programs serving employee and retiree populations. Issuing bodies include county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health and human services commissions (Texas HHS), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota, Oregon, and other participating jurisdictions). Recent solicitations show strong activity in competitive procurement with defined quantities and delivery schedules, ranging from annual naloxone and drug deactivation system purchases to large-scale generic pharmaceutical supply agreements.

Recent activity spans Florida, Texas, and the Upper Midwest. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the Seminole County Community Health Building, with bids due July 26, 2023. The City of Tampa issued IFB 26P00145 in March 2026 for 169 line items of medical and first aid supplies (estimated value $700,000) for the Tampa Fire Department Rescue Division, with award designated as a sheltered market opportunity for certified Small Local Business Enterprises and a 5 percent bid discount available. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026, requiring compliance with cGMP and Drug Supply Chain Security Act standards and pricing through authorized wholesalers including AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, and Morris & Dickson Co., LLC.